Aktis Oncology Inc
AKTS
NASDAQ
Biotechnology
$24.93
USD
+1.14 (+4.79%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.33B
Volume 229.6K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VIR | Vir Biotechnology Inc | $1.50B | - | +1496.1% | - | |
TYRA | Tyra Biosciences Inc | $1.49B | - | - | - | |
AVBP | ArriVent BioPharma Inc | $1.44B | - | - | - | |
ORIC | Oric Pharmaceuticals Inc | $1.42B | - | - | - | |
PURR | Hyperliquid Strategies Inc | $1.37B | - | - | - | |
INBX | Inhibrx Biosciences Inc | $1.37B | - | +550.0% | - | |
GLUE | Monte Rosa Therapeutics Inc | $1.35B | - | -83.9% | - | |
AKTS | Aktis Oncology Inc | $1.33B | - | +49.9% | - | |
NVAX | Novavax Inc | $1.31B | - | -61.6% | - | |
CGEM | Cullinan Therapeutics Inc | $1.26B | - | - | - | |
MGTX | MeiraGTx Holdings PLC | $1.23B | - | +131.1% | - |
Top Peer by Growth
Vir Biotechnology Inc
+1496.1% YoY Revenue
Best 1-Year Return
Inhibrx Biosciences Inc
+348.7% Return